Tirzepatide is a dual *GIP/GLP-1 receptor agonist, offering a powerful synergy for blood sugar control and aggressive fat loss. Unlike Semaglutide, it targets two pathways—enhancing insulin sensitivity, reducing appetite, slowing gastric emptying, and significantly improving metabolic function. Originally developed for type 2 diabetes, Tirzepatide has shown superior results in clinical trials for *weight reduction*, *craving control*, and *body recomposition*. It’s now a top-tier choice for serious fat loss transformations.
ALL YOU NEED TO KNOW
Recommended Male Dosage: 2.5mg–10mg, once weekly (start at 2.5mg, titrate up)
Recommended Female Dosage: 2.5mg–7.5mg, once weekly
Ideal Cycle Length: Minimum 8–12 weeks for visible fat loss; long-term use possible with monitoring













